Chris Schelling

Chief Executive Officer, Opexa Therapeutics.

Companies

Opexa TherapeuticsBoard member Sep 21, 2017 to Nov 20, 2023¹
Opexa TherapeuticsChief executive officer Sep 21, 2017 to Nov 20, 2023¹
Opexa TherapeuticsPresident Sep 21, 2017 to Nov 20, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Opexa Therapeutics0 shares²Nov 17, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 17, 2023Returned to company 2,712,529 shares of Opexa Therapeutics²
Nov 29, 2022Bought 819,672 shares at $1.22 of Opexa Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROpexa Therapeutics, Board member
2
SEC EDGAROpexa Therapeutics shares after the filing of Nov 17, 2023
3
SEC EDGARForm 4 filed Dec 1, 2022